Orencia Clinical Trials
Links shared publicly online about this topic
Bristol-Myers Says ORENCIA Trial Positive for Rheumatoid Arthritis Treatment
emaxhealth.com — “Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation of the joints and surrounding tissue causing joint damage and chronic pa...” View full resource at emaxhealth.com
Most Recently Shared on August 28, 2011 at 7:49 pm By:
@dsymons Yes, that "20% improvement = success" is part of the problem. Ex here para 4: http://t.co/t9NPdmr #rheum
Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis
news-medical.net — “Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.” View full resource at news-medical.net
Most Recently Shared on October 22, 2009 at 4:16 am By:
Lung Cancer News: Clinical data supports continued development of ORENCIA administration for r.. http://digg.com/u1EoVC
Reliable Sources: Orencia Cough Side Effect & Notions of e-Patients | Reality Check | Rheumatoid Arthritis Warrior
rawarrior.com — “If I cited a percentage of patients who get a cough from Orencia, then I--™d quote a source -- probably a clinical trial. However, if I merely say, as a...” View full resource at rawarrior.com
Most Recently Shared on March 22, 2011 at 10:00 am By:
Good morning! Today's blog is not just on side effects. It's also about whether what we say here is valid. One... http://fb.me/XWbq7GDJ
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy
medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
MNT Arthritis News Health News
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7
Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials? - QualityPoint Technologies
qualitypointtech.net — “The results of this study, conducted in Germany, re-open the debate on whether it is ethical to conduct placebo-controlled studies where patients in the placebo-group are at a serious disadvantage compared to patients taking the new treatments. The study analysed current study designs, for new therapies such as abatacept (Orencia®), golimumab (Simponi®) or tocilizumab (Actemra®), and showed that patients in the placebo group experienced no change in medication, having to continue with their form” View full resource at qualitypointtech.net
Most Recently Shared on May 30, 2011 at 8:45 am By:
Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials?: The results of this study, conducted in Ger... http://bit.ly/jzp1Bh
Medical News: Abatacept Fails in Lupus Trial - in Rheumatology, Lupus from MedPage Today
medpagetoday.com — “Treatment with abatacept (Orencia) failed to prevent flares in patients with systemic lupus erythematosus, a yearlong randomized trial found.” View full resource at medpagetoday.com
Most Recently Shared on October 7, 2010 at 6:06 pm By:
Lupus Doctor Physician, Doctor, Internist, and Rheumatologist
Orencia trial didn't meet end point:reduction in flares. But there was uggestion might help for arthritis and fatigue http://bit.ly/bsUz02
Clinical Trial: Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (ACCESS) - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (ACCESS)” View full resource at renalandurologynews.com
Most Recently Shared on March 12, 2010 at 6:11 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Clinical Trial: Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (ACCESS): A look at the fol... http://bit.ly/bTVJKB
Abatacept Fails in Lupus Trial (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Treatment with abatacept (Orencia) failed to prevent flares in patients with systemic lupus erythematosus, a yearlong randomized trial found.” View full resource at qualitypointtech.net
Most Recently Shared on October 4, 2010 at 1:36 pm By:
Abatacept Fails in Lupus Trial (CME/CE): (MedPage Today) -- Treatment with abatacept (Orencia) failed to prevent f... http://bit.ly/deFrzs
Medical News: EULAR: Abatacept Efficacy in Juvenile Arthritis Lasts Beyond Two Years - in Meeting Coverage, EULAR from MedPage Today
medpagetoday.com — “COPENHAGEN -- Children with juvenile idiopathic arthritis continued to respond to abatacept (Orencia) for up to 30 months, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on June 17, 2009 at 3:44 pm By:
CLINICAL TRIALS• EULAR: Abatacept Efficacy in Juvenile Arthritis Lasts Beyond Two Years (CME/CE) http://tinyurl.com/knbkgg
Abatacept found ineffective in treatment of non-life threatening lupus, trial results show
sciencedaily.com — “Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together.” View full resource at sciencedaily.com
Most Recently Shared on September 28, 2010 at 4:16 pm By:
Abatacept found ineffective in treatment of non-life threatening lupus, trial results show: Results from a 12-mont... http://bit.ly/bC623f
Abatacept Found Ineffective In Treatment Of Non-Life Threatening Lupus
medicalnewstoday.com — “Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept f” View full resource at medicalnewstoday.com
Most Recently Shared on September 29, 2010 at 2:13 pm By:
Abatacept Found Ineffective In Treatment Of Non-Life Threatening Lupus http://sns.ly/xrb57
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has today (30 March 2011) opened a consultation on draft guidance which does not recommend abatacept (Orencia, Bristol-Myers Squibb” View full resource at medicalnewstoday.com
Most Recently Shared on March 31, 2011 at 2:56 am By:
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis: The National Insti... http://bit.ly/dZu1fo
Abatacept Found Ineffective in Treatment of Non-Life Threatening Lupus - QualityPoint Technologies
qualitypointtech.net — “Further Trials Needed to Determine Clinical Application of Drug in SLE Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 6:36 pm By:
Abatacept Found Ineffective in Treatment of Non-Life Threatening Lupus: Further Trials Needed to Determine Clinica... http://bit.ly/csJMaF
Abatacept Ineffective in Non-life Threatening Lupus Treatment
disabled-world.com — “Abatacept found ineffective in treatment of non-life threatening lupus further trials needed to determine clinical application of drug in SLE” View full resource at disabled-world.com
Most Recently Shared on September 29, 2010 at 5:13 pm By:
Disabled World Health Advocate and Health News
Abatacept Ineffective in Non-life Threatening Lupus Treatment http://ff.im/-rj72a
Abatacept found ineffective in treatment of non-life threatening lupus
physorg.com — “Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, ...” View full resource at physorg.com
Most Recently Shared on September 28, 2010 at 5:48 pm By:
PhysOrg Health News Health News
Abatacept found ineffective in treatment of non-life threatening lupus http://tw.physorg.com/204900482
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Kelly Young
Silly.Pastors wife.Homeschool mom.Awfully grateful 2God 4heaven & this life thrown in. Creator of witty,inspiring RA blog.Support 2 fight raw,incurable disease
-
News-Medical.Net
Stay up to date with the latest Lung Cancer news and research via News-Medical.Net
-
Kelly Young
Silly.Pastors wife.Homeschool mom.Awfully grateful 2God 4heaven & this life thrown in. Creator of witty,inspiring RA blog.Support 2 fight raw,incurable disease
Advertisement
